Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.

OBJECTIVE: To determine the relation between exposure to glycaemia over time and the risk of macrovascular or microvascular complications in patients with type 2 diabetes. DESIGN: Prospective observational study. SETTING: 23 hospital based clinics in England, Scotland, and Northern Ireland. PARTICIP...

Detaylı Bibliyografya
Asıl Yazarlar:	Stratton, I, Adler, A, Neil, H, Matthews, DR, Manley, SE, Cull, C, Hadden, D, Turner, R, Holman, R
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2000

Benzer Materyaller

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study.
Yazar:: Adler, A, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75).
Yazar:: Stratton, I, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Glycaemia and vascular effects of type 2 diabetes - Reply
Yazar:: Stratton, I, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Ethnic differences in diabetic nephropathy - The UKPDS
Yazar:: Stevens, R, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.
Yazar:: Matthews, DR, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
Yazar:: Turner, R, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance.
Yazar:: Turner, R, ve diğerleri
Baskı/Yayın Bilgisi: (1991)

Effects of three months' diet after diagnosis of Type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45). UK Prospective Diabetes Study Group.
Yazar:: Manley, SE, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).
Yazar:: Adler, A, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Hyperglycemia and hyperinsulinemia at diagnosis of diabetes and their association with subsequent cardiovascular disease in the United Kingdom prospective diabetes study (UKPDS 47).
Yazar:: Adler, A, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Effects of three months' diet after diagnosis of Type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45)
Yazar:: Manley, SE, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)
Yazar:: Turner, R, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years
Yazar:: Matthews, DR, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine.
Yazar:: Kothari, V, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Plasma lipids and hypoglycaemic therapies over 6 years in Type 2 diabetic patients in the UKPDS
Yazar:: Cull, C, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Effects of three months' diet after diagnosis of type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45) (vol 17, pg 518, 2000)
Yazar:: Manley, SE, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Erratum: Effects of three months diet after diagnosis of type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45) (Diabetic Medicine (2000) 17 (518-523))
Yazar:: Manley, SE, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.
Yazar:: Stearne, MR, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group.
Yazar:: Stearne, MR, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis.
Yazar:: Stratton, I, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

The UKPDS study on glycemic control and arterial hypertension in type II diabetes: objectives, structure and preliminary results
Yazar:: Levy, J, ve diğerleri
Baskı/Yayın Bilgisi: (1993)

[The UKPDS study on glycemic control and arterial hypertension in type II diabetes: objectives, structure and preliminary results]
Yazar:: Levy, J, ve diğerleri
Baskı/Yayın Bilgisi: (1993)

Changing aspirin use in patients with Type 2 diabetes in the UKPDS.
Yazar:: Cull, C, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52).
Yazar:: Kohner, E, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Microvascular and macrovascular disease in subjects with increased but not diabetic fasting glucose levels
Yazar:: Karunakaran, S, ve diğerleri
Baskı/Yayın Bilgisi: (1996)

UKPDS 18: Estimated dietary intake in type 2 diabetic patients randomly allocated to diet, sulphonylurea or insulin therapy
Yazar:: Eeley, E, ve diğerleri
Baskı/Yayın Bilgisi: (1996)

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
Yazar:: Turner, R, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Impact of the metabolic syndrome on macrovascular and microvascular outcomes in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study 78.
Yazar:: Cull, C, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

UKPDS 18: estimated dietary intake in type 2 diabetic patients randomly allocated to diet, sulphonylurea or insulin therapy. UK Prospective Diabetes Study Group.
Yazar:: Eeley, E, ve diğerleri
Baskı/Yayın Bilgisi: (1996)

An economic evaluation of atenolol vs. captopril in patients with Type 2 diabetes (UKPDS 54).
Yazar:: Gray, A, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
Yazar:: Turner, R, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

Risk factors for neuropathy in UKPDS
Yazar:: Stratton, I, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group.
Yazar:: Horton, V, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Standardised HBA(1c) measurements are essential for the management of glycaemia as a risk factor in diabetes
Yazar:: Manley, SE, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

UK PROSPECTIVE DIABETES STUDY (UKPDS) .10. URINARY ALBUMIN EXCRETION OVER 3 YEARS IN DIET-TREATED TYPE-2, (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS, AND ASSOCIATION WITH HYPERTENSION, HYPERGLYCEMIA AND HYPERTRIGLYCERIDEMIA
Yazar:: Cull, C, ve diğerleri
Baskı/Yayın Bilgisi: (1993)

UKPDS - 6-YEAR TRIAL OF SULFONYLUREA, INSULIN AND METFORMIN THERAPY IN TYPE-2 DIABETIC-PATIENTS WITH DIET FAILURE
Yazar:: Cull, C, ve diğerleri
Baskı/Yayın Bilgisi: (1995)

Insulin sensitivity at diagnosis of Type 2 diabetes is not associated with subsequent cardiovascular disease (UKPDS 67).
Yazar:: Adler, A, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66.
Yazar:: Stevens, R, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

UKPDS: what was the question? UK Prospective Diabetes Study.
Yazar:: Turner, R, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51).
Yazar:: Clarke, P, ve diğerleri
Baskı/Yayın Bilgisi: (2001)